Novartis wins Gilenya reprieve as judge blocks generics, for now
The judge said letting generics makers sell their versions before the
patent dispute was decided would damage the Swiss drugmaker more than
those wanting a piece of Gilenya's market.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/novartis-wins-gilenya-reprieve-as-judge-blocks-generics-for-now/articleshow/69947011.cms
patent dispute was decided would damage the Swiss drugmaker more than
those wanting a piece of Gilenya's market.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/novartis-wins-gilenya-reprieve-as-judge-blocks-generics-for-now/articleshow/69947011.cms
Comments
Post a Comment